Biotron Limited Stock Current Valuation

BITRF Stock  USD 0.06  0.01  19.88%   
Valuation analysis of Biotron Limited helps investors to measure Biotron's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
0.06
Please note that Biotron's price fluctuation is out of control at this time. Calculation of the real value of Biotron Limited is based on 3 months time horizon. Increasing Biotron's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Biotron Limited is useful when determining the fair value of the Biotron pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Biotron. Since Biotron is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biotron Pink Sheet. However, Biotron's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.0585 Real  0.0492 Hype  0.06
The real value of Biotron Pink Sheet, also known as its intrinsic value, is the underlying worth of Biotron Limited Company, which is reflected in its stock price. It is based on Biotron's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Biotron's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biotron's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.05
Real Value
6.49
Upside
Estimating the potential upside or downside of Biotron Limited helps investors to forecast how Biotron pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biotron more accurately as focusing exclusively on Biotron's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.000.066.50
Details

Biotron Current Valuation Analysis

Biotron's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Biotron Current Valuation

    
  15.31 M  
Most of Biotron's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotron Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Biotron Limited has a Current Valuation of 15.31 M. This is 99.89% lower than that of the Healthcare sector and 99.67% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.91% higher than that of the company.

Biotron Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotron's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Biotron could also be used in its relative valuation, which is a method of valuing Biotron by comparing valuation metrics of similar companies.
Biotron is currently under evaluation in current valuation category among related companies.

Biotron Fundamentals

About Biotron Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Biotron Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotron using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotron Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Biotron operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biotron in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biotron's short interest history, or implied volatility extrapolated from Biotron options trading.

Pair Trading with Biotron

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotron position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotron will appreciate offsetting losses from the drop in the long position's value.

Moving against Biotron Pink Sheet

  0.79NVO Novo Nordisk AS Financial Report 2nd of May 2024 PairCorr
  0.78NONOF Novo Nordisk ASPairCorr
  0.76BRK-A Berkshire HathawayPairCorr
  0.68REGN Regeneron Pharmaceuticals Financial Report 2nd of May 2024 PairCorr
  0.51MCHB Mechanics BankPairCorr
The ability to find closely correlated positions to Biotron could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotron when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotron - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotron Limited to buy it.
The correlation of Biotron is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotron moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotron Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotron can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Biotron Piotroski F Score and Biotron Altman Z Score analysis.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Biotron Pink Sheet analysis

When running Biotron's price analysis, check to measure Biotron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotron is operating at the current time. Most of Biotron's value examination focuses on studying past and present price action to predict the probability of Biotron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotron's price. Additionally, you may evaluate how the addition of Biotron to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stocks Directory
Find actively traded stocks across global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Please note, there is a significant difference between Biotron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.